People channel feed – Endpoints News

People channel feed

Lilly opens huge new Boston research center, with a focus on genetic medicines

9 months ago

Lexicon cuts about 75 sales jobs to prep for drug launch early next year

9 months ago

Bill Haney's Dragonfly nabs former Cerevel CFO; Cellectis' new CMO

9 months ago

Infectious disease biotech undergoes makeover after lung disease trial underwhelms

9 months ago

Q&A: PhRMA CEO Stephen Ubl on the IRA, challenges to the FDA’s authority and the US-China relationship

9 months ago

Entero Therapeutics turns the lights off as creditors come calling

9 months ago

Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering

9 months ago

Bicycle Therapeutics focuses pipeline and streamlines leadership team

9 months ago

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

9 months ago

Exclusive: Biotech investor Sofinnova hires former Biogen medical chief

9 months ago

Bristol Myers to cut more jobs at headquarters as part of announced restructure

9 months ago

Q&A: Genentech's new CEO on AI, IRA and radiopharma

9 months ago

Florida CNS gene therapy biotech shuts down

9 months ago

PARP biotech backed by more than five pharmas closes after nine years

9 months ago

Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down

9 months ago

Despite recent trial success, uniQure plans to cut 65% of staff

9 months ago

Arbutus reduces headcount after axing HBV combo trial that features Imfinzi

9 months ago

Updated: Jim Wilson to step down from gene therapy post at UPenn, will form two new companies

9 months ago

After norovirus vaccine's trial failure, HilleVax lays off 40% of staff

9 months ago

FibroGen to shrink US workforce by 75% following more late-stage fails

9 months ago

Bessemer VC Morgan Cheatham shares how AI healthcare startups can win in a crowded market

10 months ago

Roivant's dealmaker lands $81M cash bonus following drug sale to Roche

10 months ago

Pfizer cuts 210 North Carolina workers after it officially discontinues failed Duchenne gene therapy

10 months ago

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

10 months ago

First page Previous page 7 8 91011 12 13 Next page Last page